Cited by 812Cardiovascular Disease and AdiposityCardiac Fibrosis and RemodelingCardiac Imaging and Diagnostics

Epicardial adipose tissue in contemporary cardiology

Open access
Iacobellis, Gianluca·2022·Nature Reviews Cardiology

Abstract

Interest in epicardial adipose tissue (EAT) is growing rapidly, and research in this area appeals to a broad, multidisciplinary audience. EAT is unique in its anatomy and unobstructed proximity to the heart and has a transcriptome and secretome very different from that of other fat depots. EAT has physiological and pathological properties that vary depending on its location. It can be highly protective for the adjacent myocardium through dynamic brown fat-like thermogenic function and harmful via paracrine or vasocrine secretion of pro-inflammatory and profibrotic cytokines. EAT is a modifiable risk factor that can be assessed with traditional and novel imaging techniques. Coronary and left atrial EAT are involved in the pathogenesis of coronary artery disease and atrial fibrillation, respectively, and it also contributes to the development and progression of heart failure. In addition, EAT might have a role in coronavirus disease 2019 (COVID-19)-related cardiac syndrome. EAT is a reliable potential therapeutic target for drugs with cardiovascular benefits such as glucagon-like peptide 1 receptor agonists and sodium-glucose co-transporter 2 inhibitors. This Review provides a comprehensive and up-to-date overview of the role of EAT in cardiovascular disease and highlights the translational nature of EAT research and its applications in contemporary cardiology.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41569-022-00679-9

Cites

159 of 159 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Perivascular and epicardial adipose tissue impose direct adverse effects on the vascular endothelium and myocardium.

    “Perivascular and epicardial adipose tissue impose direct adverse effects on the vascular endothelium and myocardium. 30”

    From Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (2023) · cites this paper as [30]

    The Introduction says epicardial adipose tissue (EAT) can harm adjacent myocardium through inflammatory and profibrotic secretions, and the Coronary artery disease section says EAT secretes factors associated with increased endothelial permeability. The paper identifies pericoronary EAT around coronary arteries, but does not establish the claim for perivascular adipose tissue generally. It also describes EAT as protective under normal conditions, so the unqualified assertion of adverse effects overstates the source. These sections have no page numbers in our copy. (LLM, conf=0.85)

    Experimental — accuracy not yet measured
  • Visceral adiposity is causally implicated in adverse cardiovascular outcomes via the release of proinflammatory cytokines.

    “Visceral adiposity in particular has been causally implicated in adverse cardiovascular outcomes via the release of proinflammatory cytokines.6”

    From Semaglutide and cardiovascular outcomes by baseline and changes in adiposity measurements: a prespecified analysis of the SELECT trial (2025) · cites this paper as [6]

    The 'Role of EAT in cardiovascular disease > Coronary artery disease' section says epicardial adipose tissue can influence coronary artery disease through the release of pro-inflammatory cytokines. That supports the proposed mechanism for this specific visceral fat depot, but does not establish the broader claim that visceral adiposity is causally implicated in adverse cardiovascular outcomes generally. The supplied passages have no page numbers. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

2 of the 161 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Iacobellis, G.
Affiliations
University of Miami (US)
Corresponding author
Iacobellis, Gianluca
Venue
Nature Reviews Cardiology
Published
2022-03-16
Volume
19
Issue
9
Pages
593-606
ISSN
  • 1759-5002 (ISSN-L)
  • 1759-5010
OpenAlex
W4220961850
Cited by
797
References
161
Citations by year
2026: 195 · 2025: 236 · 2024: 214 · 2023: 118 · 2022: 32
FWCI
31.35
Type
journal article
Language
en
Open access
Locations
  • Nature Reviews Cardiology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Cardiac Imaging and Diagnostics
Keywords
epicardial adipose tissue, coronary artery disease, atrial fibrillation, heart failure, brown fat thermogenesis, inflammatory cytokines, profibrotic cytokines, GLP-1 receptor agonists, SGLT2 inhibitors, cardiovascular risk factors
MeSH terms
COVID-19, Adipose Tissue, Atrial Fibrillation, Cardiology, Humans, Pericardium

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review